Catalog

Read with the Experts - Challenging Cases with Cardiac Amyloid
Online
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded

About this item

This is the third in a series of webinars, made possible through an unrestricted grant from Pfizer, Inc., involving a team of specialized physicians to provide education on the early diagnosis, treatment, and management of cardiac amyloidosis. There is an increasing appreciation that this disease is more prevalent than previously thought and there are newer therapies for the treatment which are important to consider in patient care. In this learning activity, challenging cases will be shared with experts to shed light on the complex issues in this disease and the role of echocardiography.

Originally Recorded April 29, 2021 | 12:00 - 1:15 PM ET

Moderator: Martha Grogan, MD

Speakers: Rodney Falk, MD; Michael Chetrit, MD; Ahmad Masri, MD, MS, and Allan Klein, MD, FASE

Learning Objectives:

  1. Understand the challenges of identifying patients with cardiac amyloidosis and have strategies for differentiating cardiac amyloidosis from other causes of increased ventricular wall thickness.
  2. Summarize the diagnostic evaluation for cardiac amyloidosis, including the differential diagnosis using echocardiography.
  3. Demonstrate an understanding of the role of multi-modality imaging in the evaluation of cardiac amyloidosis. 

This activity is FREE for ASE Members and Nonmembers. This activity offers 1 CME credit.

The webinar is the third in a series of webinars supported by an unrestricted educational grant from Pfizer. The first two webinars are accessible as on-demand activities in the Learning Hub catalogue. 

Course/Activity Information

Accreditation Statement:

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this article for a maximum of 2 hours of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s Maintenance of Certification (MOC) program, and/or the American Board of Pediatrics Maintenance of Certification (MOC) program.

ARDMS, CCI, Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.

Disclosures: 

According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.

The following moderators/speakers reported  relationships with one or more commercial interests:

  • Ahmad Masri, MD, MS - Pfizer  (Research Grant); Akcea (Research Grant); Alnylam (Consultant/Advisor); Eidos (Consultant/Advisor); Ionis (Consultant/Advisor)
  • Rodney Falk, MD - Alnylam (Consultant/Advisor); Ionis (Research Grant); Pfizer (Speakers/Speakers Bureau); Caelum (Board of Directors)
  • Martha Grogan, MD Pfizer (Research Grant); Eidos (Research Grant); Alnylam (Research Grant)
  • Michael Chetrit, MD - Alnylam (Consultant/Advisor)
  • Allan Klein, MD, FASE - Pfizer (Consultant/Advisor)

The following moderators/speakers reported no actual or potential conflicts of interest in relation to this activity:

  • None

The following CME reviewers and ASE Staff reported no actual or potential conflicts of interest in relation to this document: 

  • Kathryn Lyons, ASE Healthcare Education Manager
  • Renee Bullock-Palmer, MD, FASE
  • Matthew Parker, MD, FASE

Other information

Additional Charges May Apply

Ratings and reviews

Close
Shopping Cart
Total:  Close

Loading Shopping Cart Items...